CWGCX
Price
$81.02
Change
+$0.83 (+1.04%)
Updated
Jun 18 closing price
Net Assets
159.53B
NUGCX
Price
$35.48
Change
+$0.12 (+0.34%)
Updated
Jun 18 closing price
Net Assets
16.64M
Interact to see
Advertisement

CWGCX vs NUGCX

CWGCX vs NUGCX Comparison Chart in %
View a ticker or compare two or three
VS
CWGCX vs. NUGCX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Hold and NUGCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 160B vs. NUGCX (16.6M). CWGCX (0.75) and NUGCX (0.71) have matching dividends . CWGCX was incepted earlier than NUGCX: CWGCX (25 years) vs NUGCX (14 years). NUGCX (2.66) is less costly to investors than CWGCX (1.48). CWGCX is a more actively managed with annual turnover of: 44.00 vs. NUGCX (14.00). CWGCX has a lower initial minimum investment than NUGCX: CWGCX (250) vs NUGCX (2500). CWGCX annual gain was more profitable for investors over the last year : 20.44 vs. NUGCX (2.03). CWGCX return over 5 years is better than : 32.85 vs. NUGCX (13.97).
CWGCXNUGCXCWGCX / NUGCX
Total Expense Ratio1.481.9078%
Annual Report Gross Expense Ratio1.482.6656%
Fund Existence25 years14 years-
Gain YTD15.3283.531434%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets160B16.6M963,855%
Annual Yield % from dividends0.750.71105%
Returns for 1 year20.442.031,007%
Returns for 3 years43.6216.62262%
Returns for 5 years32.8513.97235%
Returns for 10 years95.2445.40210%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBSNX32.410.87
+2.76%
William Blair Small Cap Growth N
IEOPX15.050.27
+1.83%
Voya Large Cap Growth Port A
TSVAX22.540.34
+1.53%
PGIM Quant Solutions Small-Cap Val A
BIPIX80.881.14
+1.43%
ProFunds Biotechnology UltraSector Inv
OIEFX26.730.06
+0.22%
JPMorgan Equity Income R2